As of 2025-07-07, the Relative Valuation of Bioventus Inc (BVS) is (5.23) USD. This relative valuation is based on P/E multiples. With the latest stock price at 7.02 USD, the upside of Bioventus Inc based on Relative Valuation is -174.6%.
The range of the Relative Valuation is (4.22) - (7.18) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 11.0x - 23.9x | 13.7x |
| Forward P/E multiples | 7.2x - 18.7x | 13.5x |
| Fair Price | (4.22) - (7.18) | (5.23) |
| Upside | -160.1% - -202.3% | -174.6% |
| Date | P/E |
| 2025-07-03 | -18.24 |
| 2025-07-02 | -17.80 |
| 2025-07-01 | -18.11 |
| 2025-06-30 | -17.20 |
| 2025-06-27 | -17.59 |
| 2025-06-26 | -17.31 |
| 2025-06-25 | -17.38 |
| 2025-06-24 | -17.57 |
| 2025-06-23 | -16.94 |
| 2025-06-20 | -17.02 |
| 2025-06-18 | -16.71 |
| 2025-06-17 | -16.50 |
| 2025-06-16 | -17.15 |
| 2025-06-13 | -17.20 |
| 2025-06-12 | -17.44 |
| 2025-06-11 | -17.44 |
| 2025-06-10 | -17.83 |
| 2025-06-09 | -17.46 |
| 2025-06-06 | -17.38 |
| 2025-06-05 | -16.92 |
| 2025-06-04 | -16.97 |
| 2025-06-03 | -17.31 |
| 2025-06-02 | -16.74 |
| 2025-05-30 | -16.84 |
| 2025-05-29 | -17.05 |
| 2025-05-28 | -16.97 |
| 2025-05-27 | -16.97 |
| 2025-05-23 | -16.97 |
| 2025-05-22 | -16.92 |
| 2025-05-21 | -16.89 |
| 2025-05-20 | -18.16 |
| 2025-05-19 | -18.01 |
| 2025-05-16 | -17.64 |
| 2025-05-15 | -17.00 |
| 2025-05-14 | -16.58 |
| 2025-05-13 | -17.00 |
| 2025-05-12 | -17.51 |
| 2025-05-09 | -17.36 |
| 2025-05-08 | -17.67 |
| 2025-05-07 | -17.12 |
| 2025-05-06 | -16.11 |
| 2025-05-05 | -18.27 |
| 2025-05-02 | -19.07 |
| 2025-05-01 | -18.87 |
| 2025-04-30 | -19.00 |
| 2025-04-29 | -19.65 |
| 2025-04-28 | -19.31 |
| 2025-04-25 | -19.88 |
| 2025-04-24 | -20.09 |
| 2025-04-23 | -19.72 |